Riskpilot← Back to searchSign inGet full accessPOLYPHENOLS AS
ASActiveOrg 987444134Hanaveien 4-6, 4327 SandnesResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20042 employees
Revenue 2024
NOK 5,6M
+102% vs 2023
EBITDA margin
56.4%
+272% vs 2023
Equity ratio
71.5%
Financial strength
Net profit 2024
NOK 2,5M
+282% vs 2023
| Revenue | NOK 5,6M | +102% |
| EBITDA | NOK 3,1M | +272% |
| Net profit | NOK 2,5M | +282% |
| Total assets | NOK 9,1M | +51% |
| Equity | NOK 6,5M | +17% |
| Employees | 2 | — |
Legal name
POLYPHENOLS AS
Org number
987444134
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. november 2004
Share capital
NOK 117 184
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg.
Company purpose
Forskning, utvikling og kommersialisering av molekylstrukturer knyttet til polyphenoler og hva dermed står i naturlig forbindelse. Herunder deltakelse i, etablering av og/eller utvikling av selskaper med lignende formål. Selskapet skal også arbeide med utvikling og formidling av fou kompetanse.
Address
Hanaveien 4-6, 4327 Sandnes
Email
mail@polyphenols.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 878 | 1 645 | 1 377 | 1 396 | 978 | 989 | 952 | 2 315 | 2 579 | 1 841 | 1 637 | 1 775 | 2 270 | 2 698 | 2 665 | 2 755 | 5 564 |
| Staff expenses | −834 | −570 | −434 | −466 | −474 | −498 | −518 | −1 040 | −1 175 | −1 142 | −1 177 | −1 218 | −1 037 | −1 280 | −1 332 | −1 324 | −1 109 |
| EBITDA | −1 251 | 26 | −209 | 30 | −491 | −678 | −642 | 35 | 276 | −454 | −820 | −818 | 173 | 318 | 92 | −1 823 | 3 137 |
| Depreciation & amort. | −410 | −320 | −271 | −29 | −22 | −21 | −26 | −28 | −30 | −44 | −43 | −39 | −42 | −54 | −22 | −37 | −45 |
| EBIT | −1 661 | −293 | −480 | 2 | −513 | −699 | −668 | 7 | 246 | −498 | −863 | −857 | 132 | 264 | 70 | −1 860 | 3 092 |
| Net financials | 75 | 1 | −6 | 2 | 1 | 23 | 36 | 21 | 0 | 2 | 3 | 3 | 1 | −0 | −0 | 54 | 54 |
| Profit before tax | −1 586 | −292 | −485 | 4 | −512 | −675 | −632 | 28 | 246 | −496 | −860 | −855 | 132 | 264 | 70 | −1 806 | 3 146 |
| Tax | −0 | −0 | −0 | −1 728 | −143 | −145 | −171 | 11 | 62 | −113 | −184 | −188 | 29 | 58 | 15 | −458 | 691 |
| Net profit | −1 586 | −292 | −485 | 1 732 | −369 | −530 | −461 | 17 | 184 | −383 | −677 | −667 | 103 | 206 | 54 | −1 348 | 2 455 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 738 | 3 436 | 4 456 | 5 468 | 6 047 | 5 294 | 5 603 | 8 490 | 9 189 | 8 262 | 7 576 | 6 920 | 7 109 | 7 317 | 7 336 | 6 058 | 9 135 |
| Equity | 943 | 651 | 2 166 | 5 338 | 5 689 | 5 160 | 5 428 | 8 220 | 8 290 | 7 908 | 7 231 | 6 564 | 6 668 | 6 874 | 6 928 | 5 580 | 6 535 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 795 | 2 314 | 2 290 | 130 | 357 | 134 | 175 | 270 | 898 | 355 | 345 | 356 | 441 | 443 | 408 | 478 | 2 600 |
| Total debt | 2 795 | 2 785 | 2 290 | 130 | 357 | 134 | 175 | 270 | 898 | 355 | 345 | 356 | 441 | 443 | 408 | 478 | 2 600 |
EBITDA margin
56.4%
This company
15.8%
Market median
+257% vs market
20082024
Equity ratio
71.5%
This company
38.2%
Market median
+87% vs market
20082024
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
20082024
Net profit margin
44.1%
This company
8.1%
Market median
+444% vs market
20082024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20082024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biolink Group As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svaboe Invest As
POLYPHENOLS AS Board members of POLYPHENOLS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Larsen | Chief Executive Officer | 0 companies |
| Kåre Svaboe | Board of Directors | 0 companies |
| Sjur Svaboe | Chairman | 0 companies |